LOS
ANGELES, Nov. 16, 2022 /PRNewswire/ -- The Prostate
Cancer Foundation (PCF), the world's leading philanthropic
organization dedicated to funding life-saving prostate cancer
research, today announced that William K.
Oh, MD, an internationally recognized genitourinary (GU)
oncologist with expertise in the use of systemic treatments for
prostate cancer, has been appointed Chief Medical Officer (CMO), a
newly-created leadership position.
Dr. Oh joins PCF from Sema4, where he served as CMO of the
patient-centered health intelligence company focused on precision
medicine. He also served for over a decade as Chief of the Division
of Hematology and Medical Oncology at the Icahn School of Medicine,
Ezra Greenspan Professor of Clinical Cancer Research, and Deputy
Director of the NCI-designated Tisch Cancer Institute at Mount
Sinai.
"Dr. Oh will significantly enhance the capacity of the Prostate
Cancer Foundation to not only support the most significant science
in the world but also to deepen our understanding and address the
challenges faced by prostate cancer patients receiving care in
clinics and hospitals across the globe," says PCF President and CEO
Charles J. Ryan, MD. "In his role as
Chief Medical Officer, Dr. Oh will be a key leader of the PCF as it
works towards its mission of reducing death and suffering from
prostate cancer worldwide."
A graduate of Yale College, Dr. Oh received his MD from
New York University School of Medicine.
He completed his internship and residency in internal medicine at
Brigham and Women's Hospital in Boston and completed his medical oncology
fellowship at the Dana-Farber Cancer Institute. Dr. Oh was at the
Dana-Farber Cancer Institute and Harvard
Medical School in Boston,
MA, for 14 years, serving as Clinical Director of the Lank
Center for Genitourinary Oncology and as the founding Chair of the
Data and Safety Monitoring Committee at the Dana-Farber/Harvard
Cancer Center.
An expert in the management of GU malignancies, including
prostate, renal, bladder and testicular cancers, Dr. Oh has served
as the principal investigator of multiple clinical trials in GU
cancers. He has authored more than 350 original articles, reviews
and book chapters on topics relating to prostate, renal, bladder
and testicular cancers, and has edited three books on prostate
cancer. He has served in key invited roles for the American Society
of Clinical Oncology (ASCO), the American Cancer Society (ACS) and
the American Urological Association (AUA), including the Guidelines
Committee for Castration-Resistant Prostate Cancer. He was inducted
into the prestigious American Society for Clinical Investigation
(ASCI) and has been repeatedly selected as a Top Doctor in New York
Magazine, Castle Connolly, Best Doctors and Super Doctors through
2022.
As CMO, Dr. Oh will work to establish key fundable translational
research programs that drive improved clinical outcomes for men at
all stages of prostate cancer. Furthermore, he will focus on
understanding and reducing barriers to the effective delivery of
care and novel therapies to men with prostate cancer on a global
level. He will lead PCF's efforts to cultivate the next generation
of basic, translational and clinical prostate cancer researchers by
developing educational programs, research awards and
philanthropically funded efforts. As a key member of the leadership
team, Dr. Oh will play a key role in implementing the strategic
vision of expanding the scope and impact of PCF.
About the Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is the world's leading
philanthropic organization dedicated to funding life-saving
prostate cancer research. Founded in 1993 by Mike Milken, PCF has
been responsible for raising close to $1
billion in support of cutting-edge research by more than
2,200 research projects at 245 leading cancer centers in 28
countries around the world. Since PCF's inception, and through its
efforts, patients around the world are living longer, suffering
fewer complications, and enjoying better quality of life. PCF is
committed to creating a global public square for prostate cancer,
in service to our mission of ending death and suffering from the
disease. Learn more at pcf.org.
MEDIA CONTACT:
Staci L. Vernick
Prostate Cancer Foundation
svernick@pcf.org
press@pcf.org
610-812-6092
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-prostate-cancer-foundation-appoints-william-k-oh-md-as-chief-medical-officer-301679898.html
SOURCE Prostate Cancer Foundation
